| http://www.w3.org/ns/prov#value | - However, there was a clear relationship between the clinical outcome and the number of cycles given and the proportion of CD3+CD56+ cells in the CIK cell population, respectively.In 2009, Olioso and colleagues conducted a CIK cell therapy trial with twelve patients with advanced solid tumors including five patients with metastatic RCC [38].
|
